In vitro adrenergic modulation of cellular immune functions in experimental autoimmune encephalomyelitis

J Neuroimmunol. 2004 Jan;146(1-2):126-32. doi: 10.1016/j.jneuroim.2003.10.051.

Abstract

Objective: To analyze the effects in vitro of alpha- and beta-adrenoceptor agonists on splenocyte proliferation and on proinflammatory cytokine production in splenocytes and peritoneal macrophages (MF) in different stages of EAE.

Methods: Splenocytes and peritoneal macrophages were harvested in the acute phase of EAE and in remission, and from controls. The beta-agonist terbutaline, the alpha(1)-agonist methoxamine, and the alpha(2)-agonist UK-14304 were added with ConA or lipopolysaccharide (LPS). TNF-alpha and IFN-gamma contents in supernatant and splenocyte proliferation were determined.

Results: Terbutaline and UK-14304 significantly suppressed TNF-alpha production by MF. However, EAE acute phase rats were resistant to the suppressive effect of UK-14304. Terbutaline significantly suppressed IFN-gamma and TNF-alpha production by splenocytes. EAE acute phase and remission animals showed reduced terbutaline-induced inhibition of IFN-gamma production.

Conclusions: Disturbed sympathetic-immune communication in EAE is characterized by alterations in adrenergic sensitivity via both alpha- and beta-adrenergic pathways.

MeSH terms

  • Adrenergic Agonists / pharmacology*
  • Animals
  • Dose-Response Relationship, Drug
  • Encephalomyelitis, Autoimmune, Experimental / immunology*
  • Encephalomyelitis, Autoimmune, Experimental / metabolism
  • Immunity, Cellular / drug effects*
  • Immunity, Cellular / immunology
  • Interferon-gamma / antagonists & inhibitors
  • Interferon-gamma / biosynthesis
  • Rats
  • Receptors, Adrenergic / immunology
  • Receptors, Adrenergic / metabolism
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Adrenergic Agonists
  • Receptors, Adrenergic
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma